TRIM21 and interstitial lung disease: Consistent with previous studies by Chinese scholars, the RP-ILD incidence rate of patients with a positive anti-Ro52 antibody is higher [31–33], which is related to the acute exacerbation of IIM-ILD in the early stage of the disease [34].